TCTR20240515001尚未招募2 期
Optimal dose of simethicone administration for enhancing visibility prior to upper endoscopy A randomized, double blinded, placebo multicenter controlled trial
Internal medicine department, Suratthani Hospital0 个研究点目标入组 273 人开始时间: 2024年5月15日最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 273
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 80 Years（—）
- 性别
- All
入选标准
- •1. Chronic dyspepsia, 2. Dysphagia, 3. Esophageal varices surveillance, 4. Anemia, 5. Weight loss, 6. Vomiting, 7. Gastroesophageal reflux disease symptoms
排除标准
- •1. Upper GI bleeding, 2. Peritonitis, 3. Esophageal stricture or gastric outlet obstruction, 4. Active cardiac condition or respiratory failure, 5. Pregnancy or lactation, 6. Previous history of abdominal surgery, 7. Allergy to simethicone, 8. Not cooperate to perform an EGD
研究者
相似试验
尚未招募
不适用
A clinical study to determine the optimal dose of WIN-1001X by evaluating its efficacy and safety in patients with early Parkinson’s diseaseDiseases of the nervous systemKCT0004536Medihelpline188
尚未招募
3 期
Efficacy of addition of oral simethicone on the quality of bowel preparation for colonoscopyCTRI/2024/06/068842Sukrati Maheshwari
进行中（未招募）
不适用
Determination of the efficacious and safe dose of ivabradine in paediatric patients with dilated cardiomyopathy and symptomatic chronic heart failure aged from 6 months to less than 18 yearsEUCTR2011-001292-39-HUInstitut de Recherches Internationales Servier90
进行中（未招募）
不适用
Determination of the efficacious and safe dose of ivabradine in paediatric patients with dilated cardiomyopathy and symptomatic chronic heart failure aged from 6 months to less than 18 yearsPaediatric dilated cardiomyopathy and symptomatic chronic heart failureMedDRA version: 14.1Level: LLTClassification code 10008908Term: Chronic heart failureSystem Organ Class: 10007541 - Cardiac disordersEUCTR2011-001292-39-SEInstitut de Recherches Internationales Servier90
进行中（未招募）
1 期
Determination of the efficacious and safe dose of ivabradine in paediatric patients with dilated cardiomyopathy and symptomatic chronic heart failure aged from 6 months to less than 18 yearsPaediatric dilated cardiomyopathy and symptomatic chronic heart failureMedDRA version: 14.1Level: LLTClassification code 10008908Term: Chronic heart failureSystem Organ Class: 10007541 - Cardiac disordersEUCTR2011-001292-39-ESab Servier116